ES2089993T3 - Procedimiento y productos intermedios para la preparacion de clorhidrato de terazosina dihidrato. - Google Patents

Procedimiento y productos intermedios para la preparacion de clorhidrato de terazosina dihidrato.

Info

Publication number
ES2089993T3
ES2089993T3 ES95103188T ES95103188T ES2089993T3 ES 2089993 T3 ES2089993 T3 ES 2089993T3 ES 95103188 T ES95103188 T ES 95103188T ES 95103188 T ES95103188 T ES 95103188T ES 2089993 T3 ES2089993 T3 ES 2089993T3
Authority
ES
Spain
Prior art keywords
preparation
terazosine
chlorhydrate
dihydrate
procedure
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES95103188T
Other languages
English (en)
Other versions
ES2089993T1 (es
Inventor
Anthony Mannino
Wayne R Heitmann
Rodger F Henry
Bruce W Horrom
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=23264439&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ES2089993(T3) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of ES2089993T1 publication Critical patent/ES2089993T1/es
Application granted granted Critical
Publication of ES2089993T3 publication Critical patent/ES2089993T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cephalosporin Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

UN PROCESO PARA LA PREPARACION DE 1-(4-AMINO-6-7-DIMETOXI-2QUINAZOLINIL)-4-(2-TETRAHIDROFUROILO)PIPERACINA HIDROCLORURO (DIHIDRATO DE HIDROCLORURO DE TERAZOSINA COMPRENDE LOS PASOS DE REACCIONAR 4-AMINO-2-CLORO-6,7-DIMETOXI-QUINAZOLINA CON N-(2TETRAHIDROFUROIL)PIPERACINA EN UN SOLVENTE ORGANICO POLAR ANHIDROSO EN AUSENCIA DE UN DEPURADOR DE ACIDO AÑADIDO PARA PRODUCIR HIDROCLORURO 1-(4-AMINO-6,7-DIMETOXI-2-QUIONAZOLINIL)4-(2-TETRAHIDROFUROIL)PIPERACINA ANHIDROSO (FORMA IV) Y A CONTINUACION CONVERTIR EL PRODUCTO DE ESTE PASO EN 1-(4-AMINO6,7-DIMETOXI-2-QUINAZOLINIL)-4-(2-TETRAHIDROFUROIL)DEHIDRATADO DE HIDROCLORURO PIPERACINA.
ES95103188T 1994-10-18 1995-03-06 Procedimiento y productos intermedios para la preparacion de clorhidrato de terazosina dihidrato. Expired - Lifetime ES2089993T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/324,635 US5504207A (en) 1994-10-18 1994-10-18 Process and intermediate for the preparation of terazosin hydrochloride dihydrate

Publications (2)

Publication Number Publication Date
ES2089993T1 ES2089993T1 (es) 1996-10-16
ES2089993T3 true ES2089993T3 (es) 1997-02-16

Family

ID=23264439

Family Applications (1)

Application Number Title Priority Date Filing Date
ES95103188T Expired - Lifetime ES2089993T3 (es) 1994-10-18 1995-03-06 Procedimiento y productos intermedios para la preparacion de clorhidrato de terazosina dihidrato.

Country Status (11)

Country Link
US (1) US5504207A (es)
EP (1) EP0708104B1 (es)
JP (1) JP2711230B2 (es)
AT (1) ATE143959T1 (es)
BR (1) BR1100705A (es)
CA (1) CA2143971C (es)
DE (1) DE69500064T2 (es)
DK (1) DK0708104T3 (es)
ES (1) ES2089993T3 (es)
GR (2) GR960300047T1 (es)
HK (1) HK130297A (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5587377A (en) * 1995-10-24 1996-12-24 Invamed, Inc. Terazosin crystalline polymorph and pharmaceutical compositions thereof
DE19546573A1 (de) * 1995-12-13 1997-06-19 Uetikon Chemie Gmbh Kristallines Polymorph von Terazosin-Hydrochlorid, sowie Verfahren zu seiner Herstellung
US5952003A (en) * 1996-08-01 1999-09-14 Novartis Corporation Terazosin capsules
DE59611417D1 (de) * 1996-12-20 2007-03-29 Heumann Pharma Gmbh & Co Neue polymorphe Form von Doxazosinmesylat (Form III)
EP0849265A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von Doxazosin-Mesylat (Form II)
EP0849264A1 (de) * 1996-12-20 1998-06-24 HEUMANN PHARMA GmbH Neue polymorphe Form von doxazosinmesylat (Form I)
US6248888B1 (en) * 1997-11-14 2001-06-19 Teva Pharmaceutical Industries Ltd. Process for the preparation of terazosin hydrochloride dihydrate
US6200573B1 (en) 1999-12-03 2001-03-13 Starcor Pharmaceuticals, Inc. Method of medical management for lower urinary tract symptoms and benign prostatic hyperplasia
US20070161791A1 (en) * 2006-01-09 2007-07-12 Narsimha Reddy Penthala Process for the preparation of terazosin hydrocloride dihydrate
EP2049117A4 (en) * 2006-08-08 2010-08-25 Auspex Pharmaceuticals Inc PREPARATION AND USE OF SUBSTITUTED CHINAZOLIN COMPOUNDS WITH ALPHA-ADRENERGER BLOKING EFFECT

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4026894A (en) * 1975-10-14 1977-05-31 Abbott Laboratories Antihypertensive agents
GB1591490A (en) * 1977-08-04 1981-06-24 Abbott Lab 1-(4-amino-6,7-dimethoxy-2-quinazolinyl)-4-(2-tetrahydrofuroyl)piperazine hydrochloride dihydrate
EP0237608B1 (de) * 1986-03-21 1992-01-29 HEUMANN PHARMA GMBH & CO Kristalline, wasserfreie Sigma -Form von 2-[4-(2-Furoyl-(2-piperazin)-1-yl]-4-amino-6,7-dimethoxychinazolinhydrochlorid und Verfahren zu ihrer Herstellung
US5212176A (en) * 1990-06-29 1993-05-18 Abbott Laboratories R(+)-terazosin
WO1992003453A1 (en) * 1990-08-23 1992-03-05 Dainippon Ink & Chemicals, Inc. Antiviral agent
JP2652272B2 (ja) * 1990-12-31 1997-09-10 住化ファインケム株式会社 １−（４−アミノ−６，７−ジメトキシ−２−キナゾリニル）−４−（２−テトラヒドロフロイル）ピペラジン塩酸塩の新規な結晶体および該結晶体の製造方法
US5294615A (en) * 1993-04-29 1994-03-15 Abbott Laboratories Terazosin polymorph and pharmaceutical composition

Also Published As

Publication number Publication date
DK0708104T3 (da) 1997-03-10
EP0708104A1 (en) 1996-04-24
DE69500064D1 (de) 1996-11-14
DE69500064T2 (de) 1997-04-10
CA2143971C (en) 1997-06-03
CA2143971A1 (en) 1996-04-19
ATE143959T1 (de) 1996-10-15
GR3021319T3 (en) 1997-01-31
ES2089993T1 (es) 1996-10-16
JPH08134066A (ja) 1996-05-28
GR960300047T1 (en) 1996-08-31
HK130297A (en) 1997-09-19
US5504207A (en) 1996-04-02
BR1100705A (pt) 1999-10-13
EP0708104B1 (en) 1996-10-09
JP2711230B2 (ja) 1998-02-10

Similar Documents

Publication Publication Date Title
EA200200510A1 (ru) 4-карбоксиамино-2-этил-1,2,3,4-тетрагидрохинолин в кристаллической форме как ингибитор сетр
SE9504661D0 (sv) New compounds
EA200300211A1 (ru) Азабициклические соединения, способ их получения и их применение в качестве лекарственных средств, в частности в качестве антибактериальных средств
ES2159851T3 (es) Amidas de acidos aminotiofenocarboxilicos y su empleo como inhibidores de la fosfodiestearasa.
ES2196054T3 (es) Derivados de acido fenilacetico, procedimiento y productos intermedios para su obtencion y agentes que contienen los mismos.
ES2123810T3 (es) Heterociclos utiles como antagonistas de neuroquinina.
ES2102475T3 (es) Nuevas alquil-amidas heterociclicas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NZ521681A (en) Substituted benzoic acid amides and use thereof for the inhibition of angiogenesis
DK1311256T3 (da) Anvendelse af derivater af valproinsyreamider og 2-valproinsyreamider til behandling eller forebyggelse af smerter og/eller hovedpinelidelser
BR9509269A (pt) Processo para tratar diabetes
EA200000826A1 (ru) Галоидированные производные амидиноаминокислот, применимые в качестве ингибиторов no-синтазы
AR019496A1 (es) Azalidas de 13 miembros, composiciones farmaceuticas, uso en la preparacion de medicamentos y preparacion de los mismos
ES2089993T3 (es) Procedimiento y productos intermedios para la preparacion de clorhidrato de terazosina dihidrato.
PT1274685E (pt) Derivado de piridina-n-oxido e processo para a sua transformacao em compostos farmaceuticamente eficazes
DK1513800T3 (da) Benzoylureido-kanelsyrederivater, fremgangsmåde til deres anvendelse
ES2041705T3 (es) Procedimiento para la preparacion de 1-(4-hidroxi-3,5-di-terc-butil-benzoil)-homopiperazina y sus derivados.
SE9504662D0 (sv) New compounds
IT1293777B1 (it) Processo per la preparazione di tetraazamacrocicli
DK0891326T3 (da) Nye D-vitaminanaloger
DK1017681T3 (da) Hydrazon-benzazulenderivater, farmaceutiske præparater og mellemprodukter
DE69606777D1 (de) Naphthamidderivate von 3-beta-amino azabicyclooctan oder nonan als antipsychotische arzneimittel
EA200201003A1 (ru) Аморфная модификация торасемида
DE59010865D1 (de) N-substituierte naphthalimide, ihre herstellung und verwendung
DK1246790T3 (da) Substituerede 1- og 2-naphthol-Mannichbaser
BR9709264A (pt) Processo para produzir e composto

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 708104

Country of ref document: ES